Globus Medical (GMED) Tops Q1 EPS by 1c

Globus Medical (NYSE: GMED) reported Q1 EPS of $0.32, $0.01 better than the analyst estimate of $0.31. Revenue for the quarter came in at $155.8 million versus the consensus estimate of $149.82 million.

• Worldwide sales were $155.8 million, an increase of 11.9% as reported, or 12.1% in constant currency
• First quarter net income was $28.7 million, or 18.4% of sales
• Diluted earnings per share (EPS) were $0.30
• Non-GAAP diluted EPS were $0.32
• Non-GAAP adjusted EBITDA was 37.1% of sales

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook